Cynthia Campbell, PhD

Title(s)Professor, Psychiatry
SchoolSchool of Medicine
AddressLocation Required, #001
Phone510-891-3584
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Health Systems Node of the NIDA Clinical Trials Network
    NIH UG1DA040314Sep 1, 2015 - Feb 28, 2025
    Role: Principal Investigator
    Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence
    NIH R01DA036603Sep 15, 2014 - Aug 31, 2019
    Role: Principal Investigator
    The Impact of Health Care Reform on Addiction and HIV Services
    NIH R33DA035645May 1, 2013 - Apr 30, 2019
    Role: Co-Principal Investigator
    The Impact of Health Care Reform on Addiction and HIV Services
    NIH R21DA035645May 1, 2013 - Apr 30, 2014
    Role: Co-Principal Investigator
    High Deductible Health Plans: Substance Abuse Service Use and Cost Trajectories
    NIH R01DA030438Sep 15, 2011 - Aug 31, 2014
    Role: Principal Investigator
    Alcohol Trajectories and Service Use in Young Adults: Nine Years Post Treatment
    NIH R01AA018142May 20, 2010 - Apr 30, 2013
    Role: Principal Investigator
    Patients with Alcohol Problems and Chronic Pain: Use of Alcohol and Pain Services
    NIH R21AA016326Aug 1, 2007 - Jul 31, 2010
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Prescription Opioid Dose Reductions and Potential Adverse Events: a Multi-site Observational Cohort Study in Diverse US Health Systems. J Gen Intern Med. 2023 Nov 06. Metz VE, Ray GT, Palzes V, Binswanger I, Altschuler A, Karmali RN, Ahmedani BK, Andrade SE, Boscarino JA, Clark RE, Haller IV, Hechter RC, Roblin DW, Sanchez K, Bailey SR, McCarty D, Stephens KA, Rosa CL, Rubinstein AL, Campbell CI. PMID: 37930512.
      View in: PubMed   Mentions:    Fields:    
    2. Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial. JAMA Intern Med. 2023 Oct 30. Wartko PD, Bobb JF, Boudreau DM, Matthews AG, McCormack J, Lee AK, Qiu H, Yu O, Hyun N, Idu AE, Campbell CI, Saxon AJ, Liu DS, Altschuler A, Samet JH, Labelle CT, Zare-Mehrjerdi M, Stotts AL, Braciszewski JM, Murphy MT, Dryden D, Arnsten JH, Cunningham CO, Horigian VE, Szapocznik J, Glass JE, Caldeiro RM, Phillips RC, Shea M, Bart G, Schwartz RP, McNeely J, Liebschutz JM, Tsui JI, Merrill JO, Lapham GT, Addis M, Bradley KA, PROUD Trial Collaborators, Ghiroli MM, Hamilton LK, Hu Y, LaHue JS, Loree AM, Murphy SM, Northrup TF, Shmueli-Blumberg D, Silva AJ, Weinstein ZM, Wong MT, Burganowski RP. PMID: 37902748; PMCID: PMC10616772.
      View in: PubMed   Mentions:    Fields:    
    3. Telemedicine-delivered treatment for substance use disorder: A scoping review. J Telemed Telecare. 2023 Aug 03; 1357633X231190945. Pham H, Lin C, Zhu Y, Clingan SE, Lin LA, Mooney LJ, Murphy SM, Campbell CI, Liu Y, Hser YI. PMID: 37537907.
      View in: PubMed   Mentions:    Fields:    
    4. Patient Engagement in a Multimodal Digital Phenotyping Study of Opioid Use Disorder. J Med Internet Res. 2023 06 13; 25:e45556. Campbell CI, Chen CH, Adams SR, Asyyed A, Athale NR, Does MB, Hassanpour S, Hichborn E, Jackson-Morris M, Jacobson NC, Jones HK, Kotz D, Lambert-Harris CA, Li Z, McLeman B, Mishra V, Stanger C, Subramaniam G, Wu W, Zegers C, Marsch LA. PMID: 37310787; PMCID: PMC10337375.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Psychoactive plant derivatives (ayahuasca, ibogaine, kratom) and their application in opioid withdrawal and use disorder - a narrative review. J Addict Dis. 2023 May 18; 1-11. Arenson A, Campbell CI, Remler I. PMID: 37199191.
      View in: PubMed   Mentions:    Fields:    
    6. Overall and Telehealth Addiction Treatment Utilization by Age, Race, Ethnicity, and Socioeconomic Status in California After COVID-19 Policy Changes. JAMA Health Forum. 2023 05 05; 4(5):e231018. Palzes VA, Chi FW, Metz VE, Sterling S, Asyyed A, Ridout KK, Campbell CI. PMID: 37204804; PMCID: PMC10199344.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    7. Cannabis Use for Medical Reasons Among Patients in a Large California Health Care System After Legalization of Nonmedical Use. J Stud Alcohol Drugs. 2023 Sep; 84(5):723-733. Karmali RN, Does MB, Gordon NP, Sterling SA, Young-Wolff KC, Sidney S, Campbell CI. PMID: 37096781.
      View in: PubMed   Mentions:    Fields:    
    8. Disparities in the receipt of alcohol brief intervention: The intersectionality of sex, age, and race/ethnicity. Addiction. 2023 07; 118(7):1258-1269. Parthasarathy S, Chi FW, Metz V, Kline-Simon A, Asyyed A, Campbell CI, Sterling S. PMID: 36988614.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    9. Tobacco Smoking and Risk of SARS-CoV-2 Infection and Disease Severity Among Adults in an Integrated Healthcare System in California. Nicotine Tob Res. 2023 01 05; 25(2):211-220. Young-Wolff KC, Slama N, Alexeeff SE, Sakoda LC, Fogelberg R, Myers LC, Campbell CI, Adams AS, Prochaska JJ. PMID: 35368066; PMCID: PMC9825324.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    10. Baseline representativeness of patients in clinics enrolled in the PRimary care Opioid Use Disorders treatment (PROUD) trial: comparison of trial and non-trial clinics in the same health systems. BMC Health Serv Res. 2022 Dec 29; 22(1):1593. Wartko PD, Qiu H, Idu AE, Yu O, McCormack J, Matthews AG, Bobb JF, Saxon AJ, Campbell CI, Liu D, Braciszewski JM, Murphy SM, Burganowski RP, Murphy MT, Horigian VE, Hamilton LK, Lee AK, Boudreau DM, Bradley KA. PMID: 36581845.
      View in: PubMed   Mentions: 1     Fields:    
    11. Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States. Drug Alcohol Depend. 2023 01 01; 242:109711. Lin C, Pham H, Zhu Y, Clingan SE, Lin LA, Murphy SM, Campbell CI, Sorrell TR, Liu Y, Mooney LJ, Hser YI. PMID: 36462230; PMCID: PMC9683518.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    12. Patterns of Health Care Use 5 Years After an Intervention Linking Patients in Addiction Treatment With a Primary Care Practitioner. JAMA Netw Open. 2022 11 01; 5(11):e2241338. Iturralde E, Weisner CM, Adams SR, Chi FW, Ross TB, Cunningham SF, Ghadiali M, Asyyed AH, Satre DD, Campbell CI, Sterling SA. PMID: 36355373; PMCID: PMC9650610.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Geographic Accessibility of Retail Cannabis in Northern California and Prenatal Cannabis Use During the COVID-19 Pandemic. JAMA Netw Open. 2022 Nov 01; 5(11):e2244086. Young-Wolff KC, Slama NE, Padon AA, Silver LD, Soroosh A, Alexeeff SE, Adams SR, Does MB, Campbell CI, Ansley D, Conway A, Goler N, Avalos LA. PMID: 36445706.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsPHPublic Health
    14. Development and Testing of a Communication Intervention to Improve Chronic Pain Management in Primary Care: A Pilot Randomized Clinical Trial. Clin J Pain. 2022 10 01; 38(10):620-631. Henry SG, Fenton JJ, Campbell CI, Sullivan M, Weinberg G, Naz H, Graham WM, Dossett ML, Kravitz RL. PMID: 36037051; PMCID: PMC9481730.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Accuracy of diagnostic codes for prenatal opioid exposure and neonatal opioid withdrawal syndrome. J Perinatol. 2023 03; 43(3):293-299. Kuzniewicz MW, Campbell CI, Li S, Walsh EM, Croen LA, Comer SD, Pimentel SD, Hedderson M, Sun LS. PMID: 36131095.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. The association between buprenorphine treatment duration and mortality: a multi-site cohort study of people who discontinued treatment. Addiction. 2023 01; 118(1):97-107. Glanz JM, Binswanger IA, Clarke CL, Nguyen AP, Ford MA, Ray GT, Xu S, Hechter RC, Yarborough BJH, Roblin DW, Ahmedani B, Boscarino JA, Andrade SE, Rosa CL, Campbell CI. PMID: 35815386; PMCID: PMC9722535.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    17. Alcohol Use Among Young Adults in Northern California During the COVID-19 Pandemic-An Electronic Health Records-Based Study. Front Psychiatry. 2022; 13:883306. Metz VE, Palzes VA, Chi FW, Campbell CI, Sterling SA. PMID: 35903628; PMCID: PMC9315391.
      View in: PubMed   Mentions: 1  
    18. Sex Differences in Comorbid Mental and Substance Use Disorders Among Primary Care Patients With Opioid Use Disorder. Psychiatr Serv. 2022 Dec 01; 73(12):1330-1337. Braciszewski JM, Idu AE, Yarborough BJH, Stumbo SP, Bobb JF, Bradley KA, Rossom RC, Murphy MT, Binswanger IA, Campbell CI, Glass JE, Matson TE, Lapham GT, Loree AM, Barbosa-Leiker C, Hatch MA, Tsui JI, Arnsten JH, Stotts A, Horigian V, Hutcheson R, Bart G, Saxon AJ, Thakral M, Ling Grant D, Pflugeisen CM, Usaga I, Madziwa LT, Silva A, Boudreau DM. PMID: 35707859; PMCID: PMC9722542.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    19. Development and implementation of a prescription opioid registry across diverse health systems. JAMIA Open. 2022 Jul; 5(2):ooac030. Ray GT, Altschuler A, Karmali R, Binswanger I, Glanz JM, Clarke CL, Ahmedani B, Andrade SE, Boscarino JA, Clark RE, Haller IV, Hechter R, Roblin DW, Sanchez K, Yarborough BJ, Bailey SR, McCarty D, Stephens KA, Rosa CL, Rubinstein AL, Campbell CI. PMID: 35651523; PMCID: PMC9150082.
      View in: PubMed   Mentions: 1  
    20. Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients. JAMA Netw Open. 2022 05 02; 5(5):e2211677. Lapham GT, Matson TE, Carrell DS, Bobb JF, Luce C, Oliver MM, Ghitza UE, Hsu C, Browne KC, Binswanger IA, Campbell CI, Saxon AJ, Vandrey R, Schauer GL, Pacula RL, Horberg MA, Bailey SR, McClure EA, Bradley KA. PMID: 35604691; PMCID: PMC9127557.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    21. The Feasibility and Utility of Harnessing Digital Health to Understand Clinical Trajectories in Medication Treatment for Opioid Use Disorder: D-TECT Study Design and Methodological Considerations. Front Psychiatry. 2022; 13:871916. Marsch LA, Chen CH, Adams SR, Asyyed A, Does MB, Hassanpour S, Hichborn E, Jackson-Morris M, Jacobson NC, Jones HK, Kotz D, Lambert-Harris CA, Li Z, McLeman B, Mishra V, Stanger C, Subramaniam G, Wu W, Campbell CI. PMID: 35573377; PMCID: PMC9098973.
      View in: PubMed   Mentions: 3  
    22. The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus study. Addiction. 2022 09; 117(9):2438-2447. Karnik NS, Marsden J, McCluskey C, Boley RA, Bradley KA, Campbell CI, Curtis ME, Fiellin D, Ghitza U, Hefner K, Hser YI, McHugh RK, McPherson SM, Mooney LJ, Moran LM, Murphy SM, Schwartz RP, Shmueli-Blumberg D, Shulman M, Stephens KA, Watkins KE, Weiss RD, Wu LT. PMID: 35293064; PMCID: PMC9543602.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    23. Alcohol brief intervention, specialty treatment and drinking outcomes at 12 months: Results from a systematic alcohol screening and brief intervention initiative in adult primary care. Drug Alcohol Depend. 2022 06 01; 235:109458. Chi FW, Parthasarathy S, Palzes VA, Kline-Simon AH, Metz VE, Weisner C, Satre DD, Campbell CI, Elson J, Ross TB, Lu Y, Sterling SA. PMID: 35453082; PMCID: PMC10122418.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    24. Substance use disorders among primary care patients screening positive for unhealthy alcohol use. Fam Pract. 2022 03 24; 39(2):226-233. Metz VE, Palzes VA, Kline-Simon AH, Chi FW, Campbell CI, Weisner CM, Sterling SA. PMID: 34964877; PMCID: PMC8947771.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Mortality Among Patients Prescribed Buprenorphine for Opioid Use Disorder After Disenrollment from an Insurance Plan and Healthcare System. J Gen Intern Med. 2022 08; 37(11):2882-2884. Nguyen AP, Glanz JM, Shoup JA, Campbell CI, Clarke CL, Ford MA, Binswanger IA. PMID: 35083649; PMCID: PMC9411360.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Clinical documentation of patient-reported medical cannabis use in primary care: Toward scalable extraction using natural language processing methods. Subst Abus. 2022; 43(1):917-924. Carrell DS, Cronkite DJ, Shea M, Oliver M, Luce C, Matson TE, Bobb JF, Hsu C, Binswanger IA, Browne KC, Saxon AJ, McCormack J, Jelstrom E, Ghitza UE, Campbell CI, Bradley KA, Lapham GT. PMID: 35254218; PMCID: PMC9134865.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    27. Patient and provider factors associated with receipt and delivery of brief interventions for unhealthy alcohol use in primary care. Alcohol Clin Exp Res. 2021 10; 45(10):2179-2189. Lu Y, Chi FW, Parthasarathy S, Palzes VA, Kline-Simon AH, Metz VE, Weisner C, Satre DD, Campbell CI, Elson J, Ross TB, Awsare SV, Sterling SA. PMID: 34486124; PMCID: PMC8602748.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    28. Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems. Addict Sci Clin Pract. 2021 07 07; 16(1):46. Bagley SM, Chavez L, Braciszewski JM, Akolsile M, Boudreau DM, Lapham G, Campbell CI, Bart G, Yarborough BJH, Samet JH, Saxon AJ, Rossom RC, Binswanger IA, Murphy MT, Glass JE, Bradley KA, PROUD Collaborative. PMID: 34233750; PMCID: PMC8262000.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    29. Attention-Deficit/Hyperactivity Disorder Medication Adherence in the Transition to Adulthood: Associated Adverse Outcomes for Females and Other Disparities. J Adolesc Health. 2021 11; 69(5):806-814. Rao K, Carpenter DM, Campbell CI. PMID: 34059427.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    30. Prevalence of Medical Cannabis Use and Associated Health Conditions Documented in Electronic Health Records Among Primary Care Patients in Washington State. JAMA Netw Open. 2021 05 03; 4(5):e219375. Matson TE, Carrell DS, Bobb JF, Cronkite DJ, Oliver MM, Luce C, Ghitza UE, Hsu CW, Campbell CI, Browne KC, Binswanger IA, Saxon AJ, Bradley KA, Lapham GT. PMID: 33956129; PMCID: PMC8103224.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    31. Changes in Diagnostic and Demographic Characteristics of Patients Seeking Mental Health Care During the Early COVID-19 Pandemic in a Large, Community-Based Health Care System. J Clin Psychiatry. 2021 03 03; 82(2). Ridout KK, Alavi M, Ridout SJ, Koshy MT, Harris B, Dhillon I, Awsare S, Weisner CM, Campbell CI, Iturralde E. PMID: 33979485.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    32. Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV. J Gen Intern Med. 2021 04; 36(4):930-937. Tsui JI, Akosile MA, Lapham GT, Boudreau DM, Johnson EA, Bobb JF, Binswanger IA, Yarborough BJH, Glass JE, Rossom RC, Murphy MT, Cunningham CO, Arnsten JH, Thakral M, Saxon AJ, Merrill JO, Samet JH, Bart GB, Campbell CI, Loree AM, Silva A, Stotts AL, Ahmedani B, Braciszewski JM, Hechter RC, Northrup TF, Horigian VE, Bradley KA. PMID: 33569735; PMCID: PMC8041979.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    33. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment. Addict Sci Clin Pract. 2021 01 31; 16(1):9. Campbell CI, Saxon AJ, Boudreau DM, Wartko PD, Bobb JF, Lee AK, Matthews AG, McCormack J, Liu DS, Addis M, Altschuler A, Samet JH, LaBelle CT, Arnsten J, Caldeiro RM, Borst DT, Stotts AL, Braciszewski JM, Szapocznik J, Bart G, Schwartz RP, McNeely J, Liebschutz JM, Tsui JI, Merrill JO, Glass JE, Lapham GT, Murphy SM, Weinstein ZM, Yarborough BJH, Bradley KA. PMID: 33517894; PMCID: PMC7849121.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    34. Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): the National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus study. Trials. 2021 Jan 28; 22(1):102. Karnik NS, Campbell CI, Curtis ME, Fiellin DA, Ghitza U, Hefner K, Hser YI, McHugh RK, Murphy SM, McPherson SM, Moran L, Mooney LJ, Wu LT, Shmueli-Blumberg D, Shulman M, Schwartz RP, Stephens KA, Watkins KE, Marsden J. PMID: 33509278; PMCID: PMC7841754.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    35. Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies. J Addict Med. 2020 12; 14(6):e293-e296. Satre DD, Iturralde E, Ghadiali M, Young-Wolff KC, Campbell CI, Leibowitz AS, Sterling SA. PMID: 33156267; PMCID: PMC7892198.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    36. Health care utilization and HIV clinical outcomes among newly enrolled patients following Affordable Care Act implementation in a California integrated health system: a longitudinal study. BMC Health Serv Res. 2020 Nov 11; 20(1):1030. Satre DD, Parthasarathy S, Silverberg MJ, Horberg M, Young-Wolff KC, Williams EC, Volberding P, Campbell CI. PMID: 33176760; PMCID: PMC7656679.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    37. Healthcare utilization of individuals with substance use disorders following Affordable Care Act implementation in a California healthcare system. J Subst Abuse Treat. 2020 11; 118:108097. Satre DD, Palzes VA, Young-Wolff KC, Parthasarathy S, Weisner C, Guydish J, Campbell CI. PMID: 32972648; PMCID: PMC7519171.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    38. Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems. J Subst Abuse Treat. 2020 03; 112S:41-48. Boudreau DM, Lapham G, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Campbell CI, Rossom RC, Binswanger IA, Yarborough BJ, Arnsten JH, Cunningham CO, Glass JE, Murphy MT, Zare M, Hechter RC, Ahmedani B, Braciszewski JM, Horigian VE, Szapocznik J, Samet JH, Saxon AJ, Schwartz RP, Bradley KA. PMID: 32220410; PMCID: PMC7107675.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    39. The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose. Drug Alcohol Depend. 2020 04 01; 209:107923. Karmali RN, Ray GT, Rubinstein AL, Sterling SA, Weisner CM, Campbell CI. PMID: 32126455; PMCID: PMC7238973.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    40. Chronic pain diagnoses and opioid dispensings among insured individuals with serious mental illness. BMC Psychiatry. 2020 01 31; 20(1):40. Owen-Smith A, Stewart C, Sesay MM, Strasser SM, Yarborough BJ, Ahmedani B, Miller-Matero LR, Waring SC, Haller IV, Waitzfelder BE, Sterling SA, Campbell CI, Hechter RC, Zeber JE, Copeland LA, Scherrer JF, Rossom R, Simon G. PMID: 32005200; PMCID: PMC6995196.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    41. Long-term opioid therapy definitions and predictors: A systematic review. Pharmacoepidemiol Drug Saf. 2020 03; 29(3):252-269. Karmali RN, Bush C, Raman SR, Campbell CI, Skinner AC, Roberts AW. PMID: 31851773; PMCID: PMC7058495.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    42. Benzodiazepine and unhealthy alcohol use among adult outpatients. Am J Manag Care. 2019 12 01; 25(12):e358-e365. Hirschtritt ME, Palzes VA, Kline-Simon AH, Kroenke K, Campbell CI, Sterling SA. PMID: 31860229; PMCID: PMC7217068.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    43. Postoperative Opioid Use Before and After Enhanced Recovery After Surgery Program Implementation. Ann Surg. 2019 12; 270(6):e69-e71. Liu VX, Eaton A, Lee DC, Reyes VM, Paulson SS, Campbell CI, Avins AL, Parodi SM. PMID: 31232786; PMCID: PMC7282658.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    44. Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug Alcohol Depend. 2020 02 01; 207:107732. Lapham G, Boudreau DM, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Samet JH, Saxon AJ, Campbell CI, Glass JE, Rossom RC, Murphy MT, Binswanger IA, Yarborough BJH, Bradley KA, PROUD Collaborative Investigators. PMID: 31835068; PMCID: PMC7158756.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    45. Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and drug treatment initiation and engagement among people living with the human immunodeficiency virus (HIV) and patients without an HIV diagnosis. Subst Abus. 2019; 40(3):302-310. Hechter RC, Horberg MA, Weisner C, Campbell CI, Contreras R, Chen LH, Yarborough BJH, Lapham GT, Haller IV, Ahmedani BK, Binswanger IA, Kline-Simon AH, Satre DD. PMID: 30908174; PMCID: PMC6761030.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    46. Disparities in knowledge and use of tobacco treatment among smokers in California following healthcare reform. Prev Med Rep. 2019 Jun; 14:100847. Young-Wolff KC, Adams SR, Tan ASL, Adams AS, Klebaner D, Campbell CI, Satre DD, Salloum RG, Carter-Harris L, Prochaska JJ. PMID: 31024786; PMCID: PMC6476812.
      View in: PubMed   Mentions: 5  
    47. Patient characteristics associated with treatment initiation and engagement among individuals diagnosed with alcohol and other drug use disorders in emergency department and primary care settings. Subst Abus. 2019; 40(3):278-284. Kline-Simon AH, Stumbo SP, Campbell CI, Binswanger IA, Weisner C, Haller IV, Hechter RC, Ahmedani BK, Lapham GT, Loree AM, Sterling SA, Yarborough BJH. PMID: 30702983; PMCID: PMC6669120.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    48. Psychiatric comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and other drug treatment initiation and engagement across 7 health care systems. Subst Abus. 2019; 40(3):311-317. Loree AM, Yeh HH, Satre DD, Kline-Simon AH, Yarborough BJH, Haller IV, Campbell CI, Lapham GT, Hechter RC, Binswanger IA, Weisner C, Ahmedani BK. PMID: 30681938; PMCID: PMC6658358.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    49. The association between medical comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of treatment initiation and engagement for alcohol and other drug use disorders. Subst Abus. 2019; 40(3):292-301. Binswanger IA, Carroll NM, Ahmedani BK, Campbell CI, Haller IV, Hechter RC, McNeely J, Yarborough BJH, Kline-Simon AH, Satre DD, Weisner C, Lapham GT. PMID: 30676892; PMCID: PMC6656641.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    50. Factors associated with Healthcare Effectiveness Data and Information Set (HEDIS) alcohol and other drug measure performance in 2014-2015. Subst Abus. 2019; 40(3):318-327. Weisner C, Campbell CI, Altschuler A, Yarborough BJH, Lapham GT, Binswanger IA, Hechter RC, Ahmedani BK, Haller IV, Sterling SA, McCarty D, Satre DD, Kline-Simon AH. PMID: 30676915; PMCID: PMC6656639.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    51. Predictors of Healthcare Effectiveness Data and Information Set (HEDIS) treatment initiation and engagement among patients with opioid use disorder across 7 health systems. Subst Abus. 2019; 40(3):328-334. Campbell CI, Weisner C, Binswanger IA, Lapham GT, Ahmedani BK, Yarborough BJH, Haller IV, Altschuler A, Hechter RC, Loree AM, Kline-Simon AH. PMID: 30676931; PMCID: PMC6859006.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    52. The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems. Subst Abus. 2019; 40(3):268-277. Lapham GT, Campbell CI, Yarborough BJH, Hechter RC, Ahmedani BK, Haller IV, Kline-Simon AH, Satre DD, Loree AM, Weisner C, Binswanger IA. PMID: 30657438; PMCID: PMC6639163.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    53. Trends in marijuana use among pregnant women with and without nausea and vomiting in pregnancy, 2009-2016. Drug Alcohol Depend. 2019 03 01; 196:66-70. Young-Wolff KC, Sarovar V, Tucker LY, Avalos LA, Alexeeff S, Conway A, Armstrong MA, Weisner C, Campbell CI, Goler N. PMID: 30711893; PMCID: PMC6392046.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    54. Evaluating the Impact of Eliminating Copayments for Tobacco Cessation Pharmacotherapy. Med Care. 2018 11; 56(11):912-918. Young-Wolff KC, Adams SR, Klebaner D, Adams AS, Campbell CI, Satre DD, Prochaska JJ. PMID: 30234768; PMCID: PMC6375102.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    55. A Quality Framework for Emergency Department Treatment of Opioid Use Disorder. Ann Emerg Med. 2019 03; 73(3):237-247. Samuels EA, D'Onofrio G, Huntley K, Levin S, Schuur JD, Bart G, Hawk K, Tai B, Campbell CI, Venkatesh AK. PMID: 30318376; PMCID: PMC6817947.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    56. Characteristics of patients with substance use disorder before and after the Affordable Care Act. Drug Alcohol Depend. 2018 12 01; 193:124-130. Campbell CI, Parthasarathy S, Altschuler A, Young-Wolff KC, Satre DD. PMID: 30366189; PMCID: PMC6703160.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    57. Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization. J Affect Disord. 2018 12 01; 241:8-14. Bahorik AL, Sterling SA, Campbell CI, Weisner C, Ramo D, Satre DD. PMID: 30086434; PMCID: PMC6455811.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    58. Patient and System Characteristics Associated with Performance on the HEDIS Measures of Alcohol and Other Drug Treatment Initiation and Engagement. J Addict Med. 2018 Jul/Aug; 12(4):278-286. Yarborough BJH, Chi FW, Green CA, Hinman A, Mertens J, Beck A, Horberg M, Weisner C, Campbell CI. PMID: 29557802.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    59. Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health system. Prev Med. 2018 05; 110:31-37. Campbell CI, Bahorik AL, VanVeldhuisen P, Weisner C, Rubinstein AL, Ray GT. PMID: 29410132; PMCID: PMC6034705.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    60. Alcohol and Drug Use, Pain and Psychiatric Symptoms among Adults Seeking Outpatient Psychiatric Treatment: Latent Class Patterns and Relationship to Health Status. J Psychoactive Drugs. 2018 Jan-Mar; 50(1):43-53. Ramo DE, Bahorik AL, Delucchi KL, Campbell CI, Satre DD. PMID: 29199899; PMCID: PMC5933843.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    61. Adverse impact of marijuana use on clinical outcomes among psychiatry patients with depression and alcohol use disorder. Psychiatry Res. 2018 01; 259:316-322. Bahorik AL, Campbell CI, Sterling SA, Leibowitz A, Travis A, Weisner CM, Satre DD. PMID: 29100135; PMCID: PMC5742048.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    62. Alcohol, marijuana, and opioid use disorders: 5-Year patterns and characteristics of emergency department encounters. Subst Abus. 2018 01 02; 39(1):59-68. Bahorik AL, Satre DD, Kline-Simon AH, Weisner CM, Young-Wolff KC, Campbell CI. PMID: 28723312; PMCID: PMC5926185.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    63. Smoking Status and Opioid-related Problems and Concerns Among Men and Women on Chronic Opioid Therapy. Clin J Pain. 2017 Aug; 33(8):730-737. Young-Wolff KC, Klebaner D, Weisner C, Von Korff M, Campbell CI. PMID: 27898458; PMCID: PMC5446933.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    64. Serious mental illness and medical comorbidities: Findings from an integrated health care system. J Psychosom Res. 2017 09; 100:35-45. Bahorik AL, Satre DD, Kline-Simon AH, Weisner CM, Campbell CI. PMID: 28789791; PMCID: PMC5576509.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    65. The role of marijuana use disorder in predicting emergency department and inpatient encounters: A retrospective cohort study. Drug Alcohol Depend. 2017 09 01; 178:170-175. Campbell CI, Bahorik AL, Kline-Simon AH, Satre DD. PMID: 28651153; PMCID: PMC5605130.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    66. Prescription opioid registry protocol in an integrated health system. Am J Manag Care. 2017 May 01; 23(5):e146-e155. Ray GT, Bahorik AL, VanVeldhuisen PC, Weisner CM, Rubinstein AL, Campbell CI. PMID: 28810131; PMCID: PMC5560074.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    67. Association of the Affordable Care Act With Smoking and Tobacco Treatment Utilization Among Adults Newly Enrolled in Health Care. Med Care. 2017 05; 55(5):535-541. Young-Wolff KC, Klebaner D, Campbell CI, Weisner C, Satre DD, Adams AS. PMID: 28288073; PMCID: PMC5407463.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    68. Buprenorphine Treatment and Patient Use of Health Services after the Affordable Care Act in an Integrated Health Care System. J Psychoactive Drugs. 2017 Apr-Jun; 49(2):160-168. Campbell CI, Parthasarathy S, Young-Wolff KC, Satre DD. PMID: 28426332; PMCID: PMC5555852.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    69. The high price of depression: Family members' health conditions and health care costs. Gen Hosp Psychiatry. 2017 05; 46:79-87. Ray GT, Weisner CM, Taillac CJ, Campbell CI. PMID: 28622822.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    70. Alcohol and Drug Use and Aberrant Drug-Related Behavior Among Patients on Chronic Opioid Therapy. Subst Use Misuse. 2017 08 24; 52(10):1283-1291. Campbell CI, Kline-Simon AH, Von Korff M, Saunders KW, Weisner C. PMID: 28346056; PMCID: PMC5834235.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    71. Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records. Pharmacoepidemiol Drug Saf. 2017 May; 26(5):509-517. Green CA, Perrin NA, Janoff SL, Campbell CI, Chilcoat HD, Coplan PM. PMID: 28074520.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    72. Socioeconomic differences in adolescent substance abuse treatment participation and long-term outcomes. Addict Behav. 2017 05; 68:45-51. Lui CK, Sterling SA, Chi FW, Lu Y, Campbell CI. PMID: 28088743; PMCID: PMC5361576.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    73. Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System. J Addict Med. 2017 Jan/Feb; 11(1):3-9. Bahorik AL, Satre DD, Kline-Simon AH, Weisner CM, Campbell CI. PMID: 27610582; PMCID: PMC5291754.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    74. Implementation and Operational Research: Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics. J Acquir Immune Defic Syndr. 2016 Dec 15; 73(5):e76-e82. Satre DD, Altschuler A, Parthasarathy S, Silverberg MJ, Volberding P, Campbell CI. PMID: 27749602; PMCID: PMC5110373.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    75. Marijuana use and service utilization among adolescents 7 years post substance use treatment. Drug Alcohol Depend. 2016 Nov 01; 168:1-7. Campbell CI, Sterling S, Chi FW, Kline-Simon AH. PMID: 27606492; PMCID: PMC5297892.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    76. Protocol: changes in rates of opioid overdose and poisoning events in an integrated health system following the introduction of a formulation of OxyContin® with abuse-deterrent properties. BMC Pharmacol Toxicol. 2016 05 14; 17(1):21. Janoff SL, Perrin NA, Coplan PM, Chilcoat HD, Campbell CI, Green CA. PMID: 27177423; PMCID: PMC4867981.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    77. Demographic, Insurance, and Health Characteristics of Newly Enrolled HIV-Positive Patients After Implementation of the Affordable Care Act in California. Am J Public Health. 2016 07; 106(7):1211-3. Satre DD, Parthasarathy S, Altschuler A, Silverberg MJ, Storholm E, Campbell CI. PMID: 27077361; PMCID: PMC4902724.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    78. High-Deductible Health Plans: Implications for Substance Use Treatment. Health Serv Res. 2016 10; 51(5):1939-59. Parthasarathy S, Campbell CI. PMID: 26840191; PMCID: PMC5034209.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    79. Physician versus non-physician delivery of alcohol screening, brief intervention and referral to treatment in adult primary care: the ADVISe cluster randomized controlled implementation trial. Addict Sci Clin Pract. 2015 Nov 19; 10:26. Mertens JR, Chi FW, Weisner CM, Satre DD, Ross TB, Allen S, Pating D, Campbell CI, Lu YW, Sterling SA. PMID: 26585638; PMCID: PMC4653951.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansPHPublic Health
    80. Do patient-perceived pros and cons of opioids predict sustained higher-dose use? Clin J Pain. 2014 Feb; 30(2):93-101. Thielke SM, Turner JA, Shortreed SM, Saunders K, Leresche L, Campbell CI, Weisner CC, Korff MV. PMID: 23535150; PMCID: PMC3805783.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    81. 12-step participation and outcomes over 7 years among adolescent substance use patients with and without psychiatric comorbidity. Subst Abus. 2013; 34(1):33-42. Chi FW, Sterling S, Campbell CI, Weisner C. PMID: 23327502; PMCID: PMC3558833.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    82. Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients. Gen Hosp Psychiatry. 2012 Nov-Dec; 34(6):581-7. Merrill JO, Von Korff M, Banta-Green CJ, Sullivan MD, Saunders KW, Campbell CI, Weisner C. PMID: 22959422; PMCID: PMC3665511.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    83. Depression and ambivalence toward chronic opioid therapy for chronic noncancer pain. Clin J Pain. 2012 Sep; 28(7):561-6. Howe CQ, Sullivan MD, Saunders KW, Merrill JO, Banta-Green CJ, Weisner C, Campbell CI, Von Korff M. PMID: 22699127; PMCID: PMC3414634.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    84. Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse. Ann Fam Med. 2012 Jul-Aug; 10(4):304-11. Grattan A, Sullivan MD, Saunders KW, Campbell CI, Von Korff MR. PMID: 22778118; PMCID: PMC3392289.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    85. 12-Step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug Alcohol Depend. 2012 Nov 01; 126(1-2):124-30. Mundt MP, Parthasarathy S, Chi FW, Sterling S, Campbell CI. PMID: 22633367; PMCID: PMC3430743.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    86. Twelve-Step attendance trajectories over 7 years among adolescents entering substance use treatment in an integrated health plan. Addiction. 2012 May; 107(5):933-42. Chi FW, Campbell CI, Sterling S, Weisner C. PMID: 22151625; PMCID: PMC3311783.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    87. Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors. J Pain. 2012 Mar; 13(3):266-75. Saunders KW, Von Korff M, Campbell CI, Banta-Green CJ, Sullivan MD, Merrill JO, Weisner C. PMID: 22285611; PMCID: PMC3294025.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    88. Prescription long-term opioid use in HIV-infected patients. Clin J Pain. 2012 Jan; 28(1):39-46. Silverberg MJ, Ray GT, Saunders K, Rutter CM, Campbell CI, Merrill JO, Sullivan MD, Banta-Green CJ, Von Korff M, Weisner C. PMID: 21677568; PMCID: PMC3175344.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    89. Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy. Pain. 2011 Jun; 152(6):1256-1262. Von Korff M, Merrill JO, Rutter CM, Sullivan M, Campbell CI, Weisner C. PMID: 21296498; PMCID: PMC3098951.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    90. Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health. 2010 Dec; 100(12):2541-7. Campbell CI, Weisner C, Leresche L, Ray GT, Saunders K, Sullivan MD, Banta-Green CJ, Merrill JO, Silverberg MJ, Boudreau D, Satre DD, Von Korff M. PMID: 20724688; PMCID: PMC2978198.
      View in: PubMed   Mentions: 156     Fields:    Translation:Humans
    91. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010 Jan 19; 152(2):85-92. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, Von Korff M. PMID: 20083827; PMCID: PMC3000551.
      View in: PubMed   Mentions: 544     Fields:    Translation:Humans
    92. Ethnic disparities in accessing treatment for depression and substance use disorders in an integrated health plan. Int J Psychiatry Med. 2010; 40(1):57-76. Satre DD, Campbell CI, Gordon NS, Weisner C. PMID: 20565045; PMCID: PMC2922921.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    93. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009 Dec; 18(12):1166-75. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, Campbell CI, Merrill JO, Silverberg MJ, Banta-Green C, Weisner C. PMID: 19718704; PMCID: PMC3280087.
      View in: PubMed   Mentions: 224     Fields:    Translation:Humans
    94. Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain. 2009 Oct; 145(3):287-293. Weisner CM, Campbell CI, Ray TG, Saunders K, Merrill JO, Banta-Green C, Sullivan MD, Silverberg MJ, Mertens JR, Boudreau D, Von Korff M. PMID: 19581051; PMCID: PMC2929845.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    95. Twelve-Step affiliation and 3-year substance use outcomes among adolescents: social support and religious service attendance as potential mediators. Addiction. 2009 Jun; 104(6):927-39. Chi FW, Kaskutas LA, Sterling S, Campbell CI, Weisner C. PMID: 19344442; PMCID: PMC2722376.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansPHPublic Health
    96. Organizational determinants of outpatient substance abuse treatment duration in women. J Subst Abuse Treat. 2009 Jul; 37(1):64-72. Campbell CI, Alexander JA, Lemak CH. PMID: 19038526; PMCID: PMC2935286.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    97. Self-initiated tobacco cessation and substance use outcomes among adolescents entering substance use treatment in a managed care organization. Addict Behav. 2009 Feb; 34(2):171-9. Campbell CI, Chi F, Sterling S, Kohn C, Weisner C. PMID: 19010600; PMCID: PMC2700774.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    98. Tailoring of outpatient substance abuse treatment to women, 1995-2005. Med Care. 2007 Aug; 45(8):775-80. Campbell CI, Wells R, Alexander JA, Jiang L, Nahra TA, Lemak CH. PMID: 17667312.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    99. Tailored treatment in the outpatient substance abuse treatment sector: 1995-2005. J Subst Abuse Treat. 2008 Apr; 34(3):282-92. Alexander JA, Nahra TA, Lemak CH, Pollack H, Campbell CI. PMID: 17600653.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    100. Do licensing and accreditation matter in outpatient substance abuse treatment programs? J Subst Abuse Treat. 2007 Jul; 33(1):43-50. Wells R, Lemak CH, Alexander JA, Nahra TA, Ye Y, Campbell CI. PMID: 17588488.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    101. Adolescents entering chemical dependency treatment in private managed care: ethnic differences in treatment initiation and retention. J Adolesc Health. 2006 Apr; 38(4):343-50. Campbell CI, Weisner C, Sterling S. PMID: 16549294.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    102. Availability of services for women in outpatient substance abuse treatment: 1995-2000. J Behav Health Serv Res. 2006 Jan; 33(1):1-19. Campbell CI, Alexander JA. PMID: 16636905.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    103. Health services for women in outpatient substance abuse treatment. Health Serv Res. 2005 Jun; 40(3):781-810. Campbell CI, Alexander JA. PMID: 15960691; PMCID: PMC1361168.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    104. Changes in managed care activity in outpatient substance abuse treatment organizations, 1995-2000. J Behav Health Serv Res. 2003 Oct-Dec; 30(4):369-81. Alexander JA, Lemak CH, Campbell CI. PMID: 14593661.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    105. Culturally competent treatment practices and ancillary service use in outpatient substance abuse treatment. J Subst Abuse Treat. 2002 Apr; 22(3):109-19. Campbell CI, Alexander JA. PMID: 12039613.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Offer Student Projects

    Run Clinical Trials

    Work in Global Health Equity

    See more options in the Advanced Search tab

    Cynthia's Networks
    Concepts (278)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (19)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-2-gbbe5f151 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.